India caps 36 more drug prices; Pfizer puts $2M toward 'last-mile' vax coverage;

@FiercePharma: Top-read pharma news Thurs: Put a lid on 'Low-T' drug use, FDA panel advises, threatening AbbVie, Lilly meds. Story | Follow @FiercePharma

@EricPFierce: Potentially bad news for Amphastar and its $155.7M deal if Sanofi makes insulin for Mannkind. Story via FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: ICYMI: Protein Sciences nabs stake in diabetes vax developer Diamyd. More from FierceVaccines | Follow @CarlyHFierce

> India has put price limits on three dozen more drugs. Story

> British health workers have voted for strike action over an NHS pay freeze. More

> Pfizer ($PFE) will provide $2 million to support 'last-mile' vaccine coverage. More

> Drugstore chain Rite Aid cut its earnings forecast to a range of 22 cents to 33 cents from 30 cents to 40 cents, saying it will be dampened by contracting margins on generic drugs. Report

Medical Device News

@FierceMedDev: UDI architect shares compliance tips on eve of regulation's first deadline. More | Follow @FierceMedDev

@MichaelGFierce: Vaxxas' nanopatch garners WHO support in search of #polio vax application. Story | Follow @MichaelGFierce

@VarunSaxena2: Court ruling against FDA should enable more combination products to be classified as devices. Article | Follow @VarunSaxena2

@EmilyWFierce: San Francisco startup stirring up buzz for chicken egg facsimile, cataloging plant proteins to create new food model. Story | Follow @EmilyWFierce

> Apple HealthKit delayed by bug as major EHR players commit. Story

> British startup launches crowdfunding effort for 3-D printed orthotic devices. Article

Biotech News

@FierceBiotech: Cubist makes Euro landfall with a $400M purse for antibiotics R&D. More | Follow @FierceBiotech

@JohnCFierce: FYI, I'm setting up some meets after the executive panel in Boston next month. Details | Follow @JohnCFierce

@DamianFierce: The @FierceBiotech Fierce 15 unveiling is happening live (and live-streamed) on Monday in Boston at #BPA14. Story | Follow @DamianFierce

@EmilyMFierce: Antibiotics R&D to get critical lift by executive order, Obama advisory group. Article | Follow @EmilyMFierce

> French immuno-oncology biotech OSE eyes an EU IPO. Item

> Novo Nordisk wins EU approval for a diabetes combo with billion-dollar potential. More

> Merck KGaA rearranges its executive board amid biosimilar surge. Story

And Finally... What health issues will millennials face that their parents didn't? More (sub. req.)

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.